Jacobs Levy Equity Management
CLX icon

Jacobs Levy Equity Management’s Clorox CLX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.1M Buy
377,051
+15,571
+4% +$1.77M 0.16% 145
2025
Q4 		$36.4M Buy
361,480
+138,820
+62% +$15.1M 0.14% 138
2025
Q3 		$27.5M Sell
222,660
-11,799
-5% -$1.46M 0.11% 170
2025
Q2 		$28.2M Buy
234,459
+35,721
+18% +$4.77M 0.11% 171
2025
Q1 		$29.3M Buy
198,738
+180,238
+974% +$27.5M 0.12% 182
2024
Q4 		$3M Buy
+18,500
New +$3.03M 0.01% 525
2023
Q4 		– Sell
-14,373
Closed -$1.88M – 994
2023
Q3 		$1.88M Buy
+14,373
New +$2.18M 0.01% 567
2023
Q1 		– Sell
-157,785
Closed -$22.1M – 977
2022
Q4 		$22.1M Sell
157,785
-19,803
-11% -$2.81M 0.15% 175
2022
Q3 		$22.8M Buy
177,588
+114,331
+181% +$16.5M 0.18% 148
2022
Q2 		$8.92M Buy
+63,257
New +$9.04M 0.07% 299
2021
Q1 		– Sell
-1,629
Closed -$329K – 1028
2020
Q4 		$329K Buy
+1,629
New +$337K ﹤0.01% 908
2017
Q4 		– Sell
-2,390
Closed -$315K – 995
2017
Q3 		$315K Buy
2,390
+170
+8% +$22.8K 0.01% 781
2017
Q2 		$296K Buy
2,220
+40
+2% +$5.4K 0.01% 772
2017
Q1 		$294K Buy
+2,180
New +$282K 0.01% 726
2016
Q4 		– Sell
-2,879
Closed -$360K – 973
2016
Q3 		$360K Sell
2,879
-630
-18% -$82.5K 0.01% 771
2016
Q2 		$486K Sell
3,509
-39,310
-92% -$5.1M 0.01% 764
2016
Q1 		$5.4M Buy
42,819
+34,629
+423% +$4.4M 0.11% 218
2015
Q4 		$1.04M Buy
+8,190
New +$1.02M 0.02% 441

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jacobs Levy Equity Management's CLX Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Clorox (CLX) stake by 4.3% in Q1 2026, buying an estimated $1.77M and bringing the position to 377,051 shares worth $39.1M. The position accounts for 0.16% of the portfolio, ranked #145.

Jacobs Levy Equity Management first reported a position in CLX in Q4 2015 and has held it in 18 quarters since. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Jacobs Levy Equity Management held 377,051 shares of Clorox worth $39.1M as of Q1 2026.
  • Jacobs Levy Equity Management bought 15,571 Clorox shares in Q1 2026, an estimated $1.77M.
  • Clorox made up 0.16% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #145 holding.
  • Jacobs Levy Equity Management first reported a position in Clorox in Q4 2015 and has held it in 18 quarters since.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.